Variable | Persistent proteinuria n (%) | OR | 95% CI | P value |
---|---|---|---|---|
Median age in months (Q1;Q3) | 106 (86;121) | 1.01 | 0.99-1.04 | 0.175 |
Gender  males | 6 (5.9) | 0.69 | 0.21-2.35 | 0.557 |
     females | 5 (4.2) | |||
WAZ  ≥−2 | 3 (4.1) | 3.36 | 0.82-13.63 | 0.09 |
     <−2 | 8 (12.5) | |||
WHZ  ≥−2 | 7 (3.6) | 7.96 | 1.71-35.87 | 0.0005 |
     <−2 | 4 (22.2) | |||
eGFR(ml/min/1.73m2) | Â | Â | Â | Â |
     ≥90 | 7 (4.9) | 1.09 | 0.31-3.84 | 0.897 |
     <90 | 4 (5.3) | |||
Diastolic BP  normal | 10 (5.2) | 1.4 | 0.17-11.80 | 0.757 |
     high | 1 (7.1) | |||
Clinical stages 1&2 | 1 (1.0) | 9.17 | 1.15-72.96 | 0.036 |
Clinical stages 3&4 | 10 (8.4) | |||
Immunological stages | Â | Â | Â | Â |
Not significant | 3 (3.7) | - | - | - |
Mild | 2 (5.7) | 1.60 | 0.25-10.0 | 0.618 |
Advanced | 3 (8.6) | 2.47 | 0.47-12.88 | 0.284 |
Severe | 3 (6.5) | 1.84 | 0.36-9.50 | 0.468 |